ID   NCC-ssRMS1-C1
AC   CVCL_ZE13
DR   Wikidata; Q98127437
RX   PubMed=32300959;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~40 hours (PubMed=32300959).
CC   Sequence variation: Mutation; HGNC; 7611; MYOD1; Simple; p.Leu122Arg (c.365T>G); Zygosity=Unspecified (PubMed=32300959).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): PubMed=32300959
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D21S11: 29,31.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C121654; Spindle cell/sclerosing rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
RX   PubMed=32300959; DOI=10.1007/s13577-020-00359-1;
RA   Yoshimatsu Y., Noguchi R., Tsuchiya R., Sei A., Sugaya J., Iwata S.,
RA   Sugiyama M., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-ssRMS1-C1: a novel
RT   patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line.";
RL   Hum. Cell 33:886-893(2020).
//